Clinical Trial Update: Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants. [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study assessing the plasma concentration of tolebrutinib in adults with renal impairment compared with healthy participants; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• Tolebrutinib (tolebrutinib)

Snippet

Sponsor: Sanofi | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED